Talecris Biotherapeutics Files for $1 Billion IPO

July 30, 2007 |

1 min read

WASHINGTON, July 27 (Reuters) - Biopharmaceutical firm Talecris Biotherapeutics Holdings Corp. said on Friday it is planning a $1 billion initial public offering of common stock.

IPO

MORE ON THIS TOPIC

Confrontation and opposite opinions concept. Business people hands pulling rope in opposite directions in office showing power and leadership vector illustration

Mergers & acquisitions

Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles

March 11, 2026

·

5 min read

·

Annalee Armstrong

Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration

Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

March 6, 2026

·

1 min read

·

Annalee Armstrong

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie

Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.

Funding

Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug

March 4, 2026

·

2 min read

·

Tristan Manalac